90 related articles for article (PubMed ID: 5388434)
1. [Treatment of malignant tumor with bleomycin, with special reference to lung cancer, malignant lymphoma and leukemia].
Hiraki K; Kimura I
Nihon Ishikai Zasshi; 1969 Jul; 62(2):173-8. PubMed ID: 5388434
[No Abstract] [Full Text] [Related]
2. [Treatment of malignant tumors with bleomycin--therapeutic application in the field of internal medicine].
Kimura I; Onoshi T; Takata H; Nishizaki Y; Shirai K
Naika; 1970 Feb; 25(2):317-28. PubMed ID: 5438417
[No Abstract] [Full Text] [Related]
3. [Chemotherapy of malignant lymphoma, with special reference to the effect of bleomycin].
Kimura K; Sakai Y; Konda C; Kashiwada N; Kitahara T
Nihon Rinsho; 1969 Jun; 27(6):1593-601. PubMed ID: 5816829
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of Bleomycin in tumor pateints].
Rieche K; Matthias M
Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
[No Abstract] [Full Text] [Related]
5. [Results of a cooperative clinical study of the new antineoplastic antibiotic rubomycin].
Kachalov VK; Blokhina NG; Garin AM; Gershanovich ML; Kovaleva LG
Antibiotiki; 1969 Dec; 14(12):1059-63. PubMed ID: 4313308
[No Abstract] [Full Text] [Related]
6. [New antineoplastic agent, bleomycin, with special reference to its notable effect on squamous cell carcinoma].
Ichikawa T
Nihon Rinsho; 1969 Jun; 27(6):1618-26. PubMed ID: 5816830
[No Abstract] [Full Text] [Related]
7. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
Clavel B
Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180
[No Abstract] [Full Text] [Related]
8. [Treatment of lung tumor with bleomycin].
Oka S
Nihon Ishikai Zasshi; 1969 Jul; 62(2):126-36. PubMed ID: 5388428
[No Abstract] [Full Text] [Related]
9. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
[TBL] [Abstract][Full Text] [Related]
10. [A phase II clinical trial of pepleomycin].
Feng F; Zhang H
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):388-91. PubMed ID: 9387284
[TBL] [Abstract][Full Text] [Related]
11. Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.
Green MR; Vosika G; Propert KJ; Ware JH; Comis R
Cancer Treat Rep; 1986 Apr; 70(4):539-40. PubMed ID: 3698052
[No Abstract] [Full Text] [Related]
12. Treatment of lung cancer with bleomycin.
Oka S; Sato K; Nakai Y; Kurita K; Hashimoto K; Oshibe M
Sci Rep Res Inst Tohoku Univ Med; 1969 Oct; 16(1):30-6. PubMed ID: 5375996
[No Abstract] [Full Text] [Related]
13. [Clinical experiences with pepleomycin].
Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
Lopez M; Di Lauro L; Papaldo P; Lazzaro B
Clin Ter; 1984 Apr; 109(1):31-5. PubMed ID: 6233078
[No Abstract] [Full Text] [Related]
15. [Therapeutic and side effects of bleomycin, with special reference to histopathological study of the lung. 1. Therapeutic effects of bleomycin in cancer].
Okamura A
Nihon Kyobu Shikkan Gakkai Zasshi; 1973 May; 11(5):270-7. PubMed ID: 4125908
[No Abstract] [Full Text] [Related]
16. [Combined therapy of multiple antibiotics for malignant tumors (METT-therapy)].
Ota K; Kurita S; Nishimura M; Sugiyama Y; Ogawa M
Saishin Igaku; 1968 Mar; 23(3):631-45. PubMed ID: 4971779
[No Abstract] [Full Text] [Related]
17. [Rubidomycine. A new antineoplastic antibiotic].
Soulié L
Munch Med Wochenschr; 1968 Jun; 110(25):1539-41. PubMed ID: 5252222
[No Abstract] [Full Text] [Related]
18. Treatment of advanced non-small cell lung cancer with bisantrene.
Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
[No Abstract] [Full Text] [Related]
19. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
Myers JW; Von Hoff DD; Clark GM; Coltman CA
Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
[No Abstract] [Full Text] [Related]
20. [Treatment of lung cancer (especially small-sized) with Bleomycin--significance of CPBP therapy].
Kimura I; Moritani Y; Onoshi T; Takata H; Kunimasa I
Gan No Rinsho; 1970; 16(12):1161-70. PubMed ID: 5531009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
